Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Position in EWTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,802,829
+$1,189,150 QoQ
Shares Held
118,209
+3.0% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 223 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. EWTX ranks #63 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EWTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,802,829 118,209
2026-03-31 $3,613,679 114,720
2025-12-31 $2,433,431 98,063
2025-09-30 $2,256,395 139,112
2025-06-30 $2,511,952 191,606
2025-03-31 $6,002,854 272,857
2024-12-31 $7,452,636 279,125
2024-09-30 $2,249,805 84,294
2024-06-30 $1,438,422 79,868
2024-03-31 $591,213 32,413
2023-12-31 $258,326 23,613